References
- Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659–660
- Zukowska-Grojec E., Wahlestedt C. Origin and actions of neuro-peptide Y in the cardiovascular system. The biology of neuropeptide Y and related peptides, W. F. Colmers, C. Wahlestedt. Humana Press Inc., Totowa, NJ 1993; 315–387
- Grundemar L., Sheikh S. P., Wahlestedt C. Characterization of receptor types for neuropeptide Y and related peptides. The biology of neuropeptide Y and related peptides, W. Colmers, C. Wahlestedt. Humana Press Inc., Totowa, NJ 1993; 197–239
- Wahlestedt C., Reis D. J. Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets?. Annu. Rev. Pharmacol. Toxicol. 1993; 32: 309–352
- Glover I., Haneef I., Pitts J., Wood S., Moss D., Tickle I., Blundell T. Conformational flexibility in a small globular hormone: X-ray analysis of avian pancreatic polypeptide at 0.98-A resolution. Biopolymers 1983; 22: 293–304
- Allen J., Novotny J., Martin J., Heinrich G. Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc. Natl. Acad. Sci. USA 1987; 84: 2532–2536
- Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Reg. Peptides 1986; 13: 307–318
- Fuhlendorff J., Gether U., Aakerlund L., Langeland-Johansen N., Thøgersen H., Melberg S. G., Olsen U. B., Tharstrup O., Schwartz T. W. [Leu31,Pro34] Neuropeptide Y: A specific Y1 receptor agonist. Proc. Natl. Acad. Sci. USA 1990; 87: 182–186
- Bard J. A., Walker M. W., Branchek T. A., Weinshank R. L. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J. Biol. Chem. 1995; 270: 26762–26765
- Gehlert D. R. Subtypes of receptors for neuropeptide Y: Implications for the targeting of therapeutics. Life Sci. 1994; 55: 551–562
- Rist B., Wieland H. A., Willim K. D., Beck-Sickinger A. G. A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J. Peptide Science 1995; 1: 341–348
- Beck-Sickinger A. G., Jung G. Structure-Activity relationships of neuropeptide Y with respect to Y1 and Y2 receptors. Biopolymers 1995; 37: 123–142
- Wieland H. A., Willim K.-D., Doods H. N. Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides 1995; 16: 1389–1394
- Beck A. G., Jung G., Gaida W., Köppen H., Lang R., Schnorrenberg G. Highly potent and small neuropeptide Y agonist obtained by linking NPY 1–4 via spacer to α-helical NPY 25–36. FEBS Lett. 1989; 244: 119–122
- Beck-Sickinger A. G., Wieland H. A., Wittneben H., Willim K.-D., Rudolf K., Jung G. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations. Eur. J. Biochem. 1994; 225: 947–958
- Baldini G., Martoglio B., Schachenmann A., Zugliani C., Brunner J. Mischarging Escherichia coli tRNAPhe with L-4'-[3-trifluoromethyl)-3H-diazirin-3-yl]phenylalanine, a photoactivatable analogue of phenylalanine. Biochemistry 1988; 27: 7951–7959
- Ten Kortenaar P. B. W. T., Van Dijk B. G., Pecters J. M., Raaben B. J., Adams P. J. H. M., Tesser G. I. Rapid and efficient method for the preparation of Fmoc-amino acids starting from 9-fluorenylmethanol. Int. J. Pept. Protein Res. 1986; 27: 398–400
- Beck-Sickinger A. G., Wieland H. A., Brunner J. Synthesis, receptor binding and crosslinking of photoactive analogues of neuropeptide Y. J. of Receptor and Signal Transduction Research 1995; 15(1–4)473–485
- Colmers W. F., Klapstein G. J., Fournier A., St-Pierre S., Trehere K. A. Presynaptic inhibition of neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. J. Pharmacol. 1991; 102: 41–44
- Feinstein R. D., Boublik J. H., Kirby D. A., Spicer M. A., Craig A. G., Malwicz N. A., Scott N. A., Brown M. R., Rivier J. E. Structural requirements for neuropeptide Y18–36-evoked hypotension: A systematic study. J. Med. Chem 1992; 33: 2836–2843
- Beck-Sickinger A. G., Jung G., Gaida W., Köppen H., Schnorrenberg G., Lang R. Structure-activity relationship of C-terminal neuropeptide Y segments and analogues composed of NPY 1–4 linked to NPY 25–36. Eur. J. Biochem. 1990; 194: 449–456